List of articles with "AbbVie"

AbbVie Presents CLL Study

2026-06-12 07:21:26

USA AbbVie North Chicago CLL VENCLYXTO

Risankizumab Approval

2026-06-12 05:20:08

Japan Tokyo Crohn's Disease AbbVie Risankizumab

AbbVie Upadacitinib

2026-06-12 05:19:48

Japan Tokyo AbbVie Upadacitinib Takayasu Arteritis

AbbVie ASCO 2026 Reveal

2026-06-10 05:12:36

United States oncology AbbVie North Chicago ASCO 2026

AbbVie Blood Cancer Insights

2026-06-08 12:37:00

USA Blood Cancer Epcoritamab AbbVie North Chicago

AbbVie at EHA 2026

2026-06-08 12:18:14

USA Blood Cancer AbbVie North Chicago EHA 2026

AbbVie IBD Updates

2026-06-03 02:30:40

United States AbbVie North Chicago IBD Risankizumab

AbbVie at Goldman Sachs

2026-06-02 12:49:47

USA Goldman Sachs Healthcare Conference AbbVie North Chicago

AQUIPTA® Approval

2026-06-02 08:10:38

None AbbVie Migraine AQUIPTA

VENCLYXTO® Label Expanded

2026-05-29 12:14:35

USA AbbVie North Chicago CLL VENCLYXTO

AbbVie's VENCLYXTO Update

2026-05-29 12:13:21

USA AbbVie North Chicago CLL Treatment VENCLYXTO

FDA Approves DECNUPAZ

2026-05-27 22:20:20

USA AbbVie North Chicago BPDCN DECNUPAZ

AbbVie Makes FDA Move

2026-05-25 02:19:53

United States AbbVie North Chicago Alopecia Areata Upadacitinib

MAVIRET® Makes Headway

2026-05-22 12:13:01

USA AbbVie North Chicago Hepatitis C MAVIRET

AbbVie Crohn's Treatment

2026-05-22 02:20:27

United States Crohn's Disease AbbVie North Chicago Risankizumab

AbbVie at ASCO 2026

2026-05-21 22:59:37

United States Chicago oncology AbbVie ASCO 2026

AbbVie at Healthcare Conference

2026-05-06 12:22:57

United States Healthcare Conference pharmaceuticals AbbVie North Chicago

AbbVie IBD Treatment Data

2026-05-05 12:12:48

None Chicago AbbVie Skyrizi RINVOQ

AbbVie at AAD 2026

2026-04-30 02:40:10

USA Denver AbbVie Upadacitinib Risankizumab

AbbVie Q1 2026 Results

2026-04-29 11:50:19

USA AbbVie North Chicago Skyrizi RINVOQ

FDA Approval Request

2026-04-27 12:12:21

USA Crohn's Disease AbbVie North Chicago Skyrizi

Weekly Press Highlights

2026-04-24 10:07:29

USA New York PR Newswire Red Lobster AbbVie

AbbVie Updates on TrenibotE

2026-04-23 20:11:16

United States FDA AbbVie North Chicago TrenibotulinumtoxinE

AbbVie Expands to North Carolina

2026-04-22 16:09:12

United States Manufacturing Durham AbbVie

AbbVie Launches Aquipta

2026-04-17 01:28:17

Japan Tokyo AbbVie Migraine AQUIPTA

Haisco and AbbVie Partnership

2026-04-13 06:27:14

AbbVie pain therapy Haisco

AbbVie ELAHERE® Data

2026-04-12 11:23:17

United States San Juan AbbVie ELAHERE OvarianCancer

AbbVie at AAD 2026

2026-03-27 14:17:36

AbbVie Upadacitinib Risankizumab

CollPlant Financials 2025

2026-03-26 12:57:44

Israel CollPlant rhCollagen Rehovot AbbVie

FDA Approves Venetoclax

2026-03-25 02:54:06

United States AbbVie North Chicago CLL venetoclax

AbbVie Upadacitinib News

2026-03-23 05:27:22

Japan Tokyo AbbVie Upadacitinib Takayasu Arteritis

Skin Quality Index Launch

2026-03-16 12:12:02

USA Irvine AbbVie Allergan Aesthetics Skin Quality Index

AbbVie Upadacitinib

2026-03-13 05:29:46

Japan Tokyo AbbVie Upadacitinib Vitiligo

ABBV-295 Weight Loss

2026-03-09 12:34:55

USA Weight Management AbbVie North Chicago ABBV-295

Ubadacitinib Approval

2026-02-25 03:06:19

United States AbbVie North Chicago Vitiligo Ubadacitinib

AbbVie $380M Investment

2026-02-23 16:05:04

United States Active Pharmaceutical Ingredient AbbVie North Chicago

AbbVie Quarterly Dividend

2026-02-19 15:22:58

United States Dividend AbbVie North Chicago NYSE ABBV

AbbVie Aquipta Approval

2026-02-19 06:03:26

Japan Tokyo AbbVie Migraine AQUIPTA

AbbVie 2025 Financial Results

2026-02-04 12:56:10

United States AbbVie North Chicago Skyrizi IPRD

RINVOQ® Approval for Vitiligo

2026-02-03 13:11:50

USA AbbVie North Chicago RINVOQ Vitiligo

Biotech's $170B Patent Shift

2026-01-30 15:46:04

None Oncolytics Biotech AbbVie Genmab

Epcoritamab Phase 3 Results

2026-01-16 18:45:38

USA Epcoritamab AbbVie North Chicago DLBCL

AbbVie and Trump Agreement

2026-01-12 23:41:17

USA AbbVie North Chicago TrumpRx ALPHAGAN

AbbVie and RemeGen License Agreement

2026-01-12 12:43:48

United States AbbVie North Chicago RemeGen RC148

AbbVie Expands Arizona Facility

2026-01-12 11:04:15

United States Manufacturing Tempe Arizona AbbVie

West Transfers SmartDose® Rights

2026-01-12 11:02:59

United States Exton AbbVie West Pharmaceutical SmartDose

AbbVie Atogepant Approval

2025-12-15 05:14:05

Japan Tokyo AbbVie Migraine Atogepant

Upadacitinib for Alopecia

2025-12-15 05:13:44

Japan Tokyo AbbVie Alopecia Areata Upadacitinib

I Know IBD Wins Bronze

2025-12-11 02:36:38

Japan AbbVie Minato IBD Awareness I Know IBD

Atogepant Trial Insights

2025-12-10 05:29:28

USA AbbVie North Chicago Migraine Atogepant